Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

United Therapeutic (UTHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 5,920,884
  • Shares Outstanding, K 45,060
  • Annual Sales, $ 1,599 M
  • Annual Income, $ 713,700 K
  • 36-Month Beta 1.52
  • Price/Sales 3.73
  • Price/Cash Flow 7.53
  • Price/Book 2.88

Price Performance

See More
Period Period Low Period High Performance
1-Month
128.13 +0.10%
on 07/27/17
134.79 -4.84%
on 07/05/17
-2.68 (-2.05%)
since 06/27/17
3-Month
118.06 +8.64%
on 05/25/17
134.79 -4.84%
on 07/05/17
+7.76 (+6.44%)
since 04/27/17
52-Week
110.90 +15.65%
on 10/21/16
169.89 -24.50%
on 02/21/17
+15.06 (+13.30%)
since 07/27/16

Most Recent Stories

More News
United Therapeutics Corporation Reports Second Quarter 2017 Financial Results

United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2017.

UTHR : 126.75 (-3.54%)
Watch for United Therapeut to Potentially Pullback After Gaining 1.34% Yesterday

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $129.22 to a high of $133.61. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high...

UTHR : 126.75 (-3.54%)
After Yesterday's Rally of 1.34% Shares Could Potentially Pullback

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $129.22 to a high of $133.61. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high...

UTHR : 126.75 (-3.54%)
Look for Shares of United Therapeut to Potentially Rebound after Yesterday's 1.12% Sell Off

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $128.73 to a high of $131.15. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

UTHR : 126.75 (-3.54%)
SmarTrend Watching for Potential Rebound in Shares of United Therapeut After 1.12% Loss

United Therapeut (NASDAQ:UTHR) traded in a range yesterday that spanned from a low of $128.73 to a high of $131.15. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

UTHR : 126.75 (-3.54%)
United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017

United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2017 financial results before the market opens on Thursday, July 27, 2017.

UTHR : 126.75 (-3.54%)
E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day

E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day

JNJ : 130.16 (-0.60%)
ARNA : 24.06 (-1.27%)
ETFC : 41.28 (+0.41%)
UTHR : 126.75 (-3.54%)
STO : 18.25 (+2.13%)
Here's Why Arena Pharmaceuticals (ARNA) Stock is Skyrocketing Today

On Tuesday, shares of biopharmaceutical company Arena Pharmaceuticals (ARNA) are skyrocketing, up about 41% to $26.10 per share in afternoon trading after it reported positive mid-stage trial results for...

JNJ : 130.16 (-0.60%)
ARNA : 24.06 (-1.27%)
UTHR : 126.75 (-3.54%)
Arena's Ralinepag Positive in Phase II PAH Study, Shares Up

Arena Pharmaceuticals, Inc. (ARNA) shares surged 41.3% in after-market trading on Monday after its phase II study evaluating its key pipeline candidate, ralinepag, in pulmonary arterial hypertension,...

JNJ : 130.16 (-0.60%)
ARNA : 24.06 (-1.27%)
PFE : 32.83 (-0.18%)
UTHR : 126.75 (-3.54%)
M Pharmaceutical In-Licenses Novel Pediatric Orphan Drug to Their Pipeline, with Possible Priority Review Voucher Award

KHTRF : 7.7996 (-2.86%)
GILD : 75.17 (+1.32%)
MPHMF : 0.0400 (unch)
UTHR : 126.75 (-3.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services.

See More

Support & Resistance

2nd Resistance Point 133.68
1st Resistance Point 132.54
Last Price 127.09
1st Support Level 130.78
2nd Support Level 130.16

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.